Assembly Biosciences Stock Analysis

Assembly Stock Analysis Notes

About 32.0% of the company shares are held by company insiders. The book value of Assembly Biosciences was presently reported as 11.55. The company recorded a loss per share of 4.6. Assembly Biosciences had not issued any dividends in recent years. The entity had 1:12 split on the 12th of February 2024. Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus infection in the United States. Assembly Biosciences, Inc. was incorporated in 2005 and is headquartered in South San Francisco, California. Assembly Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 70 people. For more info on Assembly Biosciences please contact Jason JD at 833 509 4583 or go to https://www.assemblybio.com.

Assembly Biosciences Investment Alerts

Assembly Largest EPS Surprises

View All Earnings Estimates

Assembly Biosciences Environmental, Social, and Governance (ESG) Scores

Assembly Stock Institutional Investors

Note, although Assembly Biosciences' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Assembly Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 446.68 M.

Assembly Profitablity

The company has Profit Margin (PM) of (1.04) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.01) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.01.

Management Efficiency

Assembly Biosciences has return on total asset (ROA) of (0.1596) % which means that it has lost $0.1596 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3694) %, meaning that it created substantial loss on money invested by shareholders. Assembly Biosciences' management efficiency ratios could be used to measure how well Assembly Biosciences manages its routine affairs as well as how well it operates its assets and liabilities. As of February 5, 2026, Return On Tangible Assets is expected to decline to -0.32. In addition to that, Return On Capital Employed is expected to decline to -0.77. At present, Assembly Biosciences' Net Tangible Assets are projected to increase significantly based on the last few years of reporting. The current year's Intangibles To Total Assets is expected to grow to 0.31, whereas Total Assets are forecasted to decline to about 130.8 M.

Technical Drivers

As of the 5th of February, Assembly Biosciences shows the Risk Adjusted Performance of (0.01), standard deviation of 3.76, and Mean Deviation of 2.79. Assembly Biosciences technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Assembly Biosciences Price Movement Analysis

Assembly Biosciences Insider Trading Activities

Assembly Biosciences Outstanding Bonds

Assembly Biosciences Predictive Daily Indicators

Assembly Biosciences Corporate Filings

Assembly Biosciences Forecast Models

Assembly Biosciences' time-series forecasting models are one of many Assembly Biosciences' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Assembly Biosciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Assembly Biosciences Bond Ratings

Assembly Biosciences financial ratings play a critical role in determining how much Assembly Biosciences have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Assembly Biosciences' borrowing costs.

Assembly Biosciences Debt to Cash Allocation

Assembly Biosciences currently holds 3.09 M in liabilities with Debt to Equity (D/E) ratio of 0.04, which may suggest the company is not taking enough advantage from borrowing. Assembly Biosciences has a current ratio of 8.14, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Assembly Biosciences' use of debt, we should always consider it together with its cash and equity.

Assembly Biosciences Total Assets Over Time

Assembly Biosciences Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Assembly Biosciences uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Assembly Biosciences Debt Ratio

2.83

It appears most of the Assembly Biosciences' assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Assembly Biosciences' operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Assembly Biosciences, which in turn will lower the firm's financial flexibility.

Assembly Biosciences Corporate Bonds Issued

Assembly Short Long Term Debt Total

Stock analysis is the technique used by a trader or investor to examine and evaluate how Assembly Biosciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Assembly shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Assembly Biosciences. By using and applying Assembly Stock analysis, traders can create a robust methodology for identifying Assembly entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Assembly analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Assembly analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Assembly Biosciences stock analysis indicators help investors evaluate how Assembly Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Assembly Biosciences shares will generate the highest return on investment. By understating and applying Assembly Biosciences stock analysis, traders can identify Assembly Biosciences position entry and exit signals to maximize returns.

When running Assembly Biosciences' price analysis, check to measure Assembly Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Assembly Biosciences is operating at the current time. Most of Assembly Biosciences' value examination focuses on studying past and present price action to predict the probability of Assembly Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Assembly Biosciences' price. Additionally, you may evaluate how the addition of Assembly Biosciences to your portfolios can decrease your overall portfolio volatility.